Indaptus Therapeutics, Inc.
INDP
$1.73
-$0.03-1.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -172.68% | 43.10% | -15.37% | -9.72% | -34.60% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.20% | -46.69% | 302.03% | -20.78% | -31.54% |
| Change in Net Operating Assets | 3,908.56% | -144.82% | 132.07% | -275.23% | 285.69% |
| Cash from Operations | -24.27% | 36.11% | 20.39% | -48.63% | -35.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.92% | 306.76% | -83.49% | 63.12% | -28.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.33% | -1,980.00% | 98.49% | 0.57% | 18.33% |
| Cash from Financing | 162.70% | -64.43% | 99.43% | 74.90% | -30.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 907.59% | -114.65% | 219.57% | -18.93% | -2,120.15% |